Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
Journal article
Markar SR. et al, (2023), Br j surg
Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.
Journal article
Ross JDC. et al, (2023), Bmc womens health, 23
The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.
Journal article
Haydock R. et al, (2022), Trials, 23
Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
Journal article
Armstrong-Buisseret L. et al, (2022), Health technol assess, 26, 1 - 170
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.
Journal article
Goyal A. et al, (2021), Bmj open, 11
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
Journal article
Cole MJ. et al, (2020), J antimicrob chemother, 75, 449 - 457
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
Journal article
Armstrong-Buisseret L. et al, (2019), Trials, 20
Measuring patient reported outcomes in the POSNOC trial: strategies employed to promote high quality data return
Conference paper
Monson K. et al, (2019), Trials, 20
Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
Journal article
Ross JDC. et al, (2019), Lancet, 393, 2511 - 2520
Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
Journal article
Ross JD. et al, (2019), Health technol assess, 23, 1 - 104
Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.
Journal article
Anstey Watkins J. et al, (2019), Plos one, 14
Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.
Journal article
Lim WS. et al, (2017), Trials, 18
THE EFFICACY AND SAFETY OF GENTAMICIN FOR THE TREATMENT OF GENITAL, PHARYNGEAL AND RECTAL GONORRHOEA: A RANDOMISED CONTROLLED TRIAL
Conference paper
Ross JDC. et al, (2017), Sexually transmitted infections, 93, A42 - A43
Mock activation of a pandemic influenza clinical trial: testing for rapid recruitment
Conference paper
Meakin G. et al, (2017), Trials, 18
Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
Journal article
Brittain C. et al, (2016), Trials, 17
Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.
Journal article
Lim WS. et al, (2015), Health technol assess, 19, 1 - viii
Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks
Conference paper
Brittain C. et al, (2015), Trials, 16, O14 - O14
Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of ‘off the shelf' ready-to-go trials
Journal article
Whitham D. et al, (2013), Trials, 14